Bridgewater Advisors’s Idexx Laboratories IDXX Stock Holding History

Bridgewater Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-465	Closed	-$324K	–	472
2025 Q4	$324K	Buy	465 +10	+2%	+$6.81K	0.02%	339
2025 Q3	$325K	Buy	455 +20	+5%	+$12.1K	0.02%	329
2025 Q2	$249K	Buy	+435	New	+$208K	0.02%	378
2022 Q3	–	Sell	-930	Closed	-$326K	–	171
2022 Q2	$326K	Sell	930 -5	-0.5%	-$2.04K	0.07%	183
2022 Q1	$512K	Buy	935 +1	+0.1%	+$526	0.12%	140
2021 Q4	$615K	Sell	934 -200	-18%	-$126K	0.14%	130
2021 Q3	$705K	Buy	1,134 +4	+0.4%	+$2.69K	0.19%	115
2021 Q2	$714K	Buy	+1,130	New	+$624K	0.23%	106

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bridgewater Advisors's IDXX Position: Q1 2026 in Review

Bridgewater Advisors sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 465 shares — an estimated $324K sold.

Bridgewater Advisors first reported a position in IDXX in Q2 2021 and held it in 8 quarters. The position peaked at $714K in Q2 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Bridgewater Advisors reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
Bridgewater Advisors sold 465 Idexx Laboratories shares in Q1 2026, an estimated $324K.
Bridgewater Advisors first reported a position in Idexx Laboratories in Q2 2021 and held it in 8 quarters.
Bridgewater Advisors's Idexx Laboratories position peaked at $714K in Q2 2021.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Bridgewater Advisors's 13F filing for Q1 2026, filed 14 May 2026.